STAR Protocols · 2020 · 18 citations · 24 references
Life SciencesBiotechnologyCell BiologyCell TherapyGastrointestinal OncologyStem Cell BiotechnologyAnimal Cell CultureCancer Stem Cell BiologyCancer Stem CellsIntestinal DevelopmentOrganoid EngineeringAdult Stem Cell BiologyCell Type DiversityIntestinal Stem CellsLentiviral IntegrationLentiviral VectorsOrganoid CultureTransposon-based Gene TransferTransposon-mediated Integration
Patient-derived organoids maintain functional and phenotypic characteristics of the original tissue such as cell-type diversity. Here, we provide protocols on how to label intestinal (cancer) stem cells by integrating the stem cell ASCL2 reporter (STAR) into human and mouse genomes via two different strategies: (1) lentiviral transduction or (2) transposon-based integration. Organoid technology, in combination with the user-friendly nature of STAR, will facilitate basic research in human and mouse adult stem cell biology. For complete details on the use and execution of this protocol, please refer to Oost et al. (2018).
24
Sequential cancer mutations in cultured human intestinal stem cells
Jarno Drost, Richard H. van Jaarsveld, Bas Ponsioen et al. · Nature · 2015 · 1.1K citations · Full text
Visualization and targeting of LGR5+ human colon cancer stem cells
Mariko Shimokawa, Yuki Ohta, Shingo Nishikori et al. · Nature · 2017 · 749 citations
Medicine, Cell Biology, Oncology +10